London, UK, Saturday 12 April 2014: Data from a late-breaking abstract presented at the International Liver CongressTM 2014 identifies a new compound, SBEL1, that has the ability to inhibit hepatitis C virus (HCV) activity in cells at several points in the virus’ lifecycle.[1] SBEL1 is a …

READ FULL ARTICLE Curated publisher From virtualpressoffice.easl.eu